Global NK Cell Therapy Market Research Report, Competitive, Technology and Forecast Analysis 2025-2032
Description
Market Overview
According to DIResearch＇s in-depth investigation and research, the global NK Cell Therapy market size will reach 605.37 Million USD in 2025 and is projected to reach 1,949.08 Million USD by 2032, with a CAGR of 18.18% (2025-2032). Notably, the China NK Cell Therapy market has changed rapidly in the past few years. By 2025, China＇s market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
NK cell therapy, or Natural Killer cell therapy, is an emerging form of immunotherapy that harnesses the body＇s own immune system to combat cancer and other diseases. Natural Killer (NK) cells are a type of immune cell that plays a crucial role in detecting and destroying abnormal or infected cells, including cancer cells. NK cell therapy involves the isolation and expansion of these specialized immune cells from a patient＇s own body or a donor source and their subsequent infusion into the patient. The expanded NK cells are engineered or activated to enhance their ability to recognize and target cancer cells more effectively. NK cell therapy has shown promise in various cancer treatments, providing a targeted and potent immunotherapeutic approach that can work alongside or in conjunction with other cancer therapies to combat the disease and improve patient outcomes.
The major global suppliers of NK Cell Therapy include Nektar Therapeutics, Innate Pharma, Affimed, Chipscreen Biosciences, Fate Therapeutics, Glycostem Therapeutics, Dragonfly Therapeutics, Kiadis Pharma, NantWorks, Nkarta Therapeutics, Fortress Biotech, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of NK Cell Therapy. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major suppliers, as well as the market status and trends of different product types and applications in the global NK Cell Therapy market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the NK Cell Therapy market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of NK Cell Therapy industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Suppliers of NK Cell Therapy Include:
Nektar Therapeutics
Innate Pharma
Affimed
Chipscreen Biosciences
Fate Therapeutics
Glycostem Therapeutics
Dragonfly Therapeutics
Kiadis Pharma
NantWorks
Nkarta Therapeutics
Fortress Biotech
NK Cell Therapy Product Segment Include:
NK Cell Therapies
NK Cell Directed Antibodies
NK Cell Therapy Product Application Include:
Cancer
Gastrointestinal Diseases
Others
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global NK Cell Therapy Industry PESTEL Analysis
Chapter 3: Global NK Cell Therapy Industry Porter's Five Forces Analysis
Chapter 4: Global NK Cell Therapy Major Regional Market Size (Revenue) and Forecast Analysis
Chapter 5: Global NK Cell Therapy Competitive Analysis of Key Suppliers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 6: Global NK Cell Therapy Revenue and Forecast Analysis by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 8: Industrial Chain Analysis, NK Cell Therapy Different Application Market Analysis (Revenue and Forecast) and Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
According to DIResearch＇s in-depth investigation and research, the global NK Cell Therapy market size will reach 605.37 Million USD in 2025 and is projected to reach 1,949.08 Million USD by 2032, with a CAGR of 18.18% (2025-2032). Notably, the China NK Cell Therapy market has changed rapidly in the past few years. By 2025, China＇s market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
NK cell therapy, or Natural Killer cell therapy, is an emerging form of immunotherapy that harnesses the body＇s own immune system to combat cancer and other diseases. Natural Killer (NK) cells are a type of immune cell that plays a crucial role in detecting and destroying abnormal or infected cells, including cancer cells. NK cell therapy involves the isolation and expansion of these specialized immune cells from a patient＇s own body or a donor source and their subsequent infusion into the patient. The expanded NK cells are engineered or activated to enhance their ability to recognize and target cancer cells more effectively. NK cell therapy has shown promise in various cancer treatments, providing a targeted and potent immunotherapeutic approach that can work alongside or in conjunction with other cancer therapies to combat the disease and improve patient outcomes.
The major global suppliers of NK Cell Therapy include Nektar Therapeutics, Innate Pharma, Affimed, Chipscreen Biosciences, Fate Therapeutics, Glycostem Therapeutics, Dragonfly Therapeutics, Kiadis Pharma, NantWorks, Nkarta Therapeutics, Fortress Biotech, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of NK Cell Therapy. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major suppliers, as well as the market status and trends of different product types and applications in the global NK Cell Therapy market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the NK Cell Therapy market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of NK Cell Therapy industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Suppliers of NK Cell Therapy Include:
Nektar Therapeutics
Innate Pharma
Affimed
Chipscreen Biosciences
Fate Therapeutics
Glycostem Therapeutics
Dragonfly Therapeutics
Kiadis Pharma
NantWorks
Nkarta Therapeutics
Fortress Biotech
NK Cell Therapy Product Segment Include:
NK Cell Therapies
NK Cell Directed Antibodies
NK Cell Therapy Product Application Include:
Cancer
Gastrointestinal Diseases
Others
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global NK Cell Therapy Industry PESTEL Analysis
Chapter 3: Global NK Cell Therapy Industry Porter's Five Forces Analysis
Chapter 4: Global NK Cell Therapy Major Regional Market Size (Revenue) and Forecast Analysis
Chapter 5: Global NK Cell Therapy Competitive Analysis of Key Suppliers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 6: Global NK Cell Therapy Revenue and Forecast Analysis by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 8: Industrial Chain Analysis, NK Cell Therapy Different Application Market Analysis (Revenue and Forecast) and Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
Table of Contents
165 Pages
- 1 NK Cell Therapy Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 NK Cell Therapy Product by Type
- 1.2.1 NK Cell Therapies
- 1.2.2 NK Cell Directed Antibodies
- 1.3 NK Cell Therapy Product by Application
- 1.3.1 Cancer
- 1.3.2 Gastrointestinal Diseases
- 1.3.3 Others
- 1.4 Global NK Cell Therapy Market Size Analysis (2020-2032)
- 1.5 NK Cell Therapy Market Development Status and Trends
- 1.5.1 NK Cell Therapy Industry Development Status Analysis
- 1.5.2 NK Cell Therapy Industry Development Trends Analysis
- 2 NK Cell Therapy Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 NK Cell Therapy Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global NK Cell Therapy Market Analysis by Country
- 4.1 Global NK Cell Therapy Market Size Analysis by Country: 2024 VS 2025 VS 2032
- 4.1.1 Global NK Cell Therapy Revenue Analysis by Country (2020-2025)
- 4.1.2 Global NK Cell Therapy Revenue Forecast Analysis by Country (2026-2032)
- 4.2 United States NK Cell Therapy Market Revenue and Growth Rate (2020-2032)
- 4.3 Germany NK Cell Therapy Market Revenue and Growth Rate (2020-2032)
- 4.4 Japan NK Cell Therapy Market Revenue and Growth Rate (2020-2032)
- 4.5 China NK Cell Therapy Market Revenue and Growth Rate (2020-2032)
- 4.6 France NK Cell Therapy Market Revenue and Growth Rate (2020-2032)
- 4.7 U.K. NK Cell Therapy Market Revenue and Growth Rate (2020-2032)
- 4.8 South Korea NK Cell Therapy Market Revenue and Growth Rate (2020-2032)
- 4.9 Canada NK Cell Therapy Market Revenue and Growth Rate (2020-2032)
- 4.10 Italy NK Cell Therapy Market Revenue and Growth Rate (2020-2032)
- 4.11 Russia NK Cell Therapy Market Revenue and Growth Rate (2020-2032)
- 4.12 Mexico NK Cell Therapy Market Revenue and Growth Rate (2020-2032)
- 4.13 Brazil NK Cell Therapy Market Revenue and Growth Rate (2020-2032)
- 4.14 India NK Cell Therapy Market Revenue and Growth Rate (2020-2032)
- 4.15 Vietnam NK Cell Therapy Market Revenue and Growth Rate (2020-2032)
- 4.16 Thailand NK Cell Therapy Market Revenue and Growth Rate (2020-2032)
- 4.17 South Africa NK Cell Therapy Market Revenue and Growth Rate (2020-2032)
- 5 Competition by Suppliers
- 5.1 Global NK Cell Therapy Market Revenue by Key Suppliers (2021-2025)
- 5.2 NK Cell Therapy Competitive Landscape Analysis and Market Dynamic
- 5.2.1 NK Cell Therapy Competitive Landscape Analysis
- 5.2.2 Global Key Suppliers Headquarter and Key Area Sales
- 5.2.3 Market Dynamic
- 6 NK Cell Therapy Market Analysis by Type
- 6.1 Global NK Cell Therapy Market Size Analysis by Type: 2024 VS 2025 VS 2032
- 6.2 Global NK Cell Therapy Revenue and Forecast Analysis by Type (2020-2032)
- 7 Key Companies Analysis
- 7.1 Nektar Therapeutics
- 7.1.1 Nektar Therapeutics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.1.2 Nektar Therapeutics NK Cell Therapy Product Portfolio
- 7.1.3 Nektar Therapeutics NK Cell Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.2 Innate Pharma
- 7.2.1 Innate Pharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.2.2 Innate Pharma NK Cell Therapy Product Portfolio
- 7.2.3 Innate Pharma NK Cell Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.3 Affimed
- 7.3.1 Affimed Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.3.2 Affimed NK Cell Therapy Product Portfolio
- 7.3.3 Affimed NK Cell Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.4 Chipscreen Biosciences
- 7.4.1 Chipscreen Biosciences Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.4.2 Chipscreen Biosciences NK Cell Therapy Product Portfolio
- 7.4.3 Chipscreen Biosciences NK Cell Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.5 Fate Therapeutics
- 7.5.1 Fate Therapeutics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.5.2 Fate Therapeutics NK Cell Therapy Product Portfolio
- 7.5.3 Fate Therapeutics NK Cell Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.6 Glycostem Therapeutics
- 7.6.1 Glycostem Therapeutics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.6.2 Glycostem Therapeutics NK Cell Therapy Product Portfolio
- 7.6.3 Glycostem Therapeutics NK Cell Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.7 Dragonfly Therapeutics
- 7.7.1 Dragonfly Therapeutics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.7.2 Dragonfly Therapeutics NK Cell Therapy Product Portfolio
- 7.7.3 Dragonfly Therapeutics NK Cell Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.8 Kiadis Pharma
- 7.8.1 Kiadis Pharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.8.2 Kiadis Pharma NK Cell Therapy Product Portfolio
- 7.8.3 Kiadis Pharma NK Cell Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.9 NantWorks
- 7.9.1 NantWorks Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.9.2 NantWorks NK Cell Therapy Product Portfolio
- 7.9.3 NantWorks NK Cell Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.10 Nkarta Therapeutics
- 7.10.1 Nkarta Therapeutics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.10.2 Nkarta Therapeutics NK Cell Therapy Product Portfolio
- 7.10.3 Nkarta Therapeutics NK Cell Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.11 Fortress Biotech
- 7.11.1 Fortress Biotech Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.11.2 Fortress Biotech NK Cell Therapy Product Portfolio
- 7.11.3 Fortress Biotech NK Cell Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 8 Industry Chain Analysis
- 8.1 NK Cell Therapy Industry Chain Analysis
- 8.2 NK Cell Therapy Product Downstream Application Analysis
- 8.2.1 Global NK Cell Therapy Market Size and Growth Rate (CAGR) by Application: 2024 VS 2025 VS 2032
- 8.2.2 Global NK Cell Therapy Revenue and Forecast by Application (2020-2032)
- 8.3 NK Cell Therapy Typical Downstream Customers
- 8.4 NK Cell Therapy Sales Channel Analysis
- 9 Research Findings and Conclusion
- 10 Methodology and Data Source
- 10.1 Methodology/Research Approach
- 10.2 Research Scope
- 10.3 Benchmarks and Assumptions
- 10.4 Date Source
- 10.4.1 Primary Sources
- 10.4.2 Secondary Sources
- 10.5 Data Cross Validation
- 10.6 Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
